The fascinating class of SCD activators encompasses a diverse array of chemical entities, each playing a distinctive role in either directly or, more commonly, indirectly upregulating the activity of Stearoyl-CoA Desaturase (SCD). These activators engage in complex networks of metabolic regulation, instigating signaling cascades or binding to transcription factors that orchestrate the expression or functionality of SCD. The intricate pathways through which these chemicals operate highlight the multifaceted nature of cellular metabolism and its regulation. One well-characterized pathway involves the activation of peroxisome proliferator-activated receptors (PPARs) by thiazolidinediones like Pioglitazone and Rosiglitazone. This activation initiates transcriptional programs that include the upregulation of genes crucial for fatty acid metabolism, with SCD being a key player in this metabolic orchestra. Another avenue involves the activation of the insulin signaling pathway, wherein phosphorylation events cascade, mobilizing transcription factors like SREBP-1c that directly enhance the transcription of the SCD gene. These pathways underscore the intricate dance of cellular signaling and transcriptional control in regulating SCD activity.
Beyond receptor-mediated pathways, some SCD activators function by altering the intracellular milieu, creating a state that necessitates enhanced SCD activity. For instance, certain fatty acids like oleic acid act as signaling molecules indicating a cellular need for more desaturated fats, thereby upregulating SCD. AMP-activated protein kinase (AMPK) activators, such as Metformin, showcase dual roles. Their primary function involves the activation of energy-sensing pathways, but secondarily, they influence lipid biosynthesis, culminating in the upregulation of SCD. This nuanced interplay illustrates that while these activators may not directly bind to SCD, they evoke a cellular response that strategically places SCD at a pivotal point for maintaining lipid homeostasis. Collectively, SCD activators showcase the central role of SCD in integrating various metabolic signals. This integration modulates lipid composition, cell membrane fluidity, and overall cellular lipid homeostasis.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin interacts with its receptor to activate the PI3K/Akt signaling pathway, which can increase the expression of SCD by promoting transcription factors like SREBP-1c that drive SCD gene transcription. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMP-activated protein kinase (AMPK), which can indirectly upregulate SCD expression by modulating SREBP-1 activity and enhancing fatty acid synthesis pathways. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
As a PPAR-gamma agonist, Pioglitazone can upregulate SCD1 expression through the activation of PPAR-responsive elements in the SCD gene promoter region. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Similar to Pioglitazone, Rosiglitazone activates PPAR-gamma, leading to an upregulation of genes involved in fatty acid metabolism including SCD1. | ||||||
Ob (hBA-147) | sc-4912 | 1000 µg | $258.00 | 1 | ||
Ob (hBA-147) can modulate SCD activity indirectly by affecting central nervous system regulation of energy homeostasis and potentially altering SREBP-1c mediated SCD gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, through its receptor, influences gene expression and can upregulate SCD1 as part of a broader modulation of lipid metabolism. | ||||||
T 0901317 | 293754-55-9 | sc-202824 sc-202824A | 10 mg 50 mg | $89.00 $224.00 | 5 | |
LXR agonists bind to liver X receptors (LXR), which can increase SCD1 gene expression as part of a wider regulation of lipid and cholesterol metabolism. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Oleic acid can upregulate SCD expression through a feedback mechanism that modulates the need for desaturated fatty acids within cells. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
Arachidonic acid can modulate SCD activity indirectly by affecting eicosanoid signaling, which can influence lipid metabolism and SCD expression levels. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
DHA can regulate SCD activity by modifying the lipid composition of cellular membranes and influencing the broader lipid signaling and metabolism pathways. | ||||||